ChronoScale Holdings Corp
corporate_fare Company Profile
ChronoScale Holdings Corp (NASDAQ:CHRN) is a publicly traded company in the Technology sector. Wiseek has independently scored 11 items for CHRN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-02, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 10/10, with 8 rated 8 or above. Recent SEC coverage for CHRN spans 8-K, PRER14A, 10-K, 8-K/A.
Recent high-impact activity:
- ChronoScale Completes Ekso Bionics Sale, Terminates COO, and Withdraws Series B Preferred Stock
- $1 Billion AI Revenue Secured, ChronoScale Divests Bionics Unit
- CTO Rajasekar Jegannathan Resigns Effective October 2, 2026
- ChronoScale Extends Microsoft AI Compute Partnership to Three Years
- ChronoScale and Microsoft Plan 50 MW AI Compute Deployment with NVIDIA GB300 Systems
Financial Snapshot
Short Interest & Short Volume
5.18 days to coverFINRA reported short interest of 701,226 shares in CHRN as of the September 15, 2026 settlement, a 9.8% increase from the prior period — about 5.2 days to cover at its recent average daily volume. On October 2, 2026, 55.8% of CHRN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for CHRN, detected from its recent SEC filings.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →